Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .教師升等新聘著作
  4. 101學年度
  5. 林俊茂教師資格審查資料
 
  • Details
Options

林俊茂教師資格審查資料

Type
report
Date Issued
2012
Author(s)
林俊茂  
Subjects
類別:升等
送審等級:教授
Description
101-1升等
教師升等著作
聘任單位:醫學系生化學科
送審等級:教授
審查性質:專門著作-學術
代表著作:C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide
URI
https://203.71.86.71/handle/123456789/7233
File(s)
No Thumbnail Available
Name

C0218517.pdf

Size

65.05 MB

Format

Adobe PDF

Checksum

(MD5):26538c2b03d1ed25677e32d100c28e7b

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback